A Message from Our CEO Regarding COVID-19
Clinical Maestro eases management of change orders 2021-04-07T12:46:16+00:00

Strategikon Pharma Announces New Software Release of Clinical Maestro

Latest Version Establishes Clinical Maestro as a Digital Business Transformation Leader for Clinical Trials

SAN FRANCISCO, April 7, 2021 — Strategikon Pharma announced a global update for its Clinical Maestro™ platform that advances capabilities for tracking out of scope services (aka change orders) and improves flexibility for service providers responding to RFPs through Clinical Maestro.

The LEAD module of Clinical Maestro focuses on Accruals & Forecasting. Within this module, providers can now add ‘out of scope’ changes related to minor tasks (in the contract or new) for the Sponsor’s review and negotiation. This functionality incorporates a comprehensive comments module, which documents and tracks this process for both Sponsors and Providers. Once approved, out of scope items are integrated into the next unit reports so that Providers can report consistently on the task including the updated scope.

This comprehensive release offers additional features that enhance clinical study planning, budgeting, and outsourcing through the Clinical Maestro platform, such as:

  • Providers can self-manage their team access to speed RFP responses
  • Both Sponsors and Providers can set top-level budget discounts that propagate to underlying categories, applicable to scenarios, RFPs, and bids.
  • Providers can modify and add tasks from Clinical Maestro’s bid grid on flexible bids
  • Enhanced data visualization tools for budgeting and service categories ease vetting during the bidding process

“As Strategikon’s customer base expands, we are continually refining the Clinical Maestro platform for both Sponsors and Providers. We have seen increased sophistication and major improvements in our clients’ clinical business operations in just the last twelve months,” said Anca Copaescu, CEO of Strategikon Pharma.  “Clinical trials are very dynamic in nature and this is especially true for decentralized trials. Robust Out of Scope and Change management capability is vital for both sides to be able to accurately track study budgets and progress against goals. The ability to quickly and easily generate accurate budgets and RFPs and to respond to requests helps improve the agility of both Sponsors and CROs and better their time to market.”

Please join us for a free webinar to learn more from an industry peer:

Embracing Change and Budgeting Technology during a Pandemic

Thu, Apr 15, 2021 12:00 PM – 1:00 PM EDT

CSL Behring will share their experiences on introducing and implementing study budgeting technology for their Global Clinical organization. Learn about the challenges they faced and overcame, what could be done differently, whether it was worth it, and tips that can help your own organization.

About Clinical Maestro™ by Strategikon Pharma

Clinical Maestro is the cloud-based platform that modernizes outsourcing for clinical programs. It enables all participants in clinical trials, Sponsor Companies, Vendors and Service Providers, to plan studies, model and manage clinical contracts in an entirely systematic way. Budget, source and manage, faster, more accurately, and with less effort. For more information, please visit  www.clinicalmaestro.com.

Contact:

Karen Wills

Strategikon Pharma

617-899-0986

kwills@strategikonpharma.com

Download PDF